Pfizer building $200M facility in Chesterfield; retain 450+ jobs

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

FILE - An exterior photograph of the Pfizer headquarters in New York, New York.

CLAYTON, MO (KPLR) – Pfizer is building a new $200 million facility in Chesterfield for research and development.  St. Louis County says the development will create more than 80 jobs and retain 450 positions.

Construction of the facility is expected to begin in 2017.  It will be designed to develop biotherapeutic molecules like vaccines, immune-oncology therapies.  Pfizer plans to bring employes from two sites together once the new building is complete.

“Missouri is an important part of Pfizer’s research and development network, we’re proud of the world-class employee base we’ve built here,” said John Ludwig, Senior Vice President of BioTherapeutics Research in a statement.

Pfizer received support from the state of Missouri, St. Louis County and Chesterfield to build the new $200 million facility.

Pfizer is one of the world’s largest biopharmaceutical companies.  They are headquartered in New York and have been located in St. Louis for the past 13 years.   The company has labs, office space and manufacturing operations in two locations in St. Louis County.  They focus biotherapeutics and vaccine development in the area.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.